Jeffrey Wasser

4PUBLICATIONS
19CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Respiratory diseasesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 27, 2022
First-in-human study of an OX40 (ivuxolimab) and 4-1BB (utomilumab) agonistic antibody combination in patients with advanced solid tumors.

Omid Hamid, Alberto A Chiappori, John A Thompson

|May 23, 2020
Treatment Patterns Among Adults with Primary Immune Thrombocytopenia Diagnosed in Hematology Clinics in the United States.

Leah J McGrath, Karynsa Kilpatrick, Robert A Overman

|Feb 28, 2020
Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non-Small Cell Lung Cancer.

Charu Aggarwal, Jeffrey C Thompson, Austin L Chien

|Nov 13, 2015
Tumor-Unrelated CD4 T Cell Help Augments CD134 plus CD137 Dual Costimulation Tumor Therapy.

Payal Mittal, Marie-Clare St Rose, Xi Wang

Pageof 1